ORPHA:1489
Whooping cough
Synonyms: Pertussis
- Type
- Disease
- Group
- Disorder
- Age of onset
- All ages
- Status
- active
A rare bacterial infectious disease characterized by severe coughing paroxysms with inspiratory whooping and posttussive vomiting, caused by infection with <i>Bordetella pertussis</i>. After a variable incubation time, the clinical course progresses through a catarrhal stage with sore throat, nasal congestion, rhinorrhea, and mild progressive dry cough, a paroxysmal stage with the typical paroxysmal coughing, and finally convalescence. Disease duration is usually 2-3 months, often with milder presentation in adolescents and adults than in infants and children.
1
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Whooping cough | Pertussis |
| fr | Coqueluche | = en |
| de | Keuchhusten | = en |
| es | Tos ferina | Tosferina |
| it | Tosse canina | Pertosse |
| nl | Kinkhoest | = en |
| pt | Tosse convulsa | = en |
| pl | Krztusiec | = en |
| cs | Černý kašel | Pertusse · Dávivý kašel |
| uk | Кашлюк | Кашлюк |
| zh | 百日咳 | 百日咳 |
| tr | Boğmaca | Boğmaca |
Definition in:
2
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| ICD-10 | A37.0 | BTNT | specific | validated |
| ICD-10 | A37.1 | BTNT | specific | validated |
| ICD-10 | A37.8 | BTNT | specific | validated |
| ICD-10 | A37.9 | BTNT | specific | validated |
| ICD-11 | 1C12.0 | E | specific | validated |
| MONDO | 0005077 | E | validated | |
| MeSH | D014917 | E | validated | |
| UMLS | C0043167 | E | validated | |
| GARD | 8692 | E | validated | |
| MedDRA | 10047974 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
3
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:163582Rare bacterial infectious disease
rare infectious diseases
No children.
4
Genes
0 directOrphanet records no gene directly on this code.
5
Prevalence and incidence
30 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Annual incidence | 1-9 / 100 000 | 8.9 / 100 000 | Europe | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 2.22 / 100 000 | Lithuania | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 2.14 / 100 000 | Luxembourg | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 1 000 000 | 0.52 / 100 000 | Malta | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-5 / 10 000 | 31.72 / 100 000 | Netherlands | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-5 / 10 000 | 47.24 / 100 000 | Norway | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-5 / 10 000 | 10.6 / 100 000 | Poland | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 2.1 / 100 000 | Portugal | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 1 000 000 | 0.42 / 100 000 | Romania | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-5 / 10 000 | 10.5 / 100 000 | Slovakia | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 9.5 / 100 000 | Slovenia | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 8.3 / 100 000 | Spain | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 6.2 / 100 000 | Sweden | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 8.5 / 100 000 | United Kingdom | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 9.76 / 100 000 | Austria | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-5 / 10 000 | 10.08 / 100 000 | Belgium | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 1.08 / 100 000 | Bulgaria | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 1 000 000 | 0.88 / 100 000 | Cyprus | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-5 / 10 000 | 10.7 / 100 000 | Czech Republic | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-5 / 10 000 | 19.16 / 100 000 | Denmark | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 4.66 / 100 000 | Estonia | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 5.1 / 100 000 | Finland | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-5 / 10 000 | 15.4 / 100 000 | Germany | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 1 000 000 | 0.38 / 100 000 | Greece | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 1 000 000 | 0.16 / 100 000 | Hungary | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 2.34 / 100 000 | Croatia | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 5.3 / 100 000 | Iceland | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 3.58 / 100 000 | Ireland | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 1.2 / 100 000 | Italy | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
| Annual incidence | 1-9 / 100 000 | 8.48 / 100 000 | Latvia | Value and class | Validated | European Centre for Disease prevention and Control 2013-2017[OTHER] |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
6
HPO phenotypes
Orphanet has no HPO annotation for this code in this release.
7
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/1489
- This record as JSON: /data/d/1489.json